Abstract
The management of lung carcinomas, whether small cell or non-small cell, frequently requires a combination of radiation and systemic treatment, both in curative and palliative strategies. However, the introduction of new systemic treatments raises the issue of the feasibility of such combinations due to a significant risk of toxicity. This literature review aims to evaluate the risk situations for toxicity when combining radiation with systemic treatment. In certain situations, optimizing the method of irradiation (sequence, dose) is necessary to improve both feasibility and effectiveness.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
